We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Noninvasive Technology Monitors People with Diabetes

By LabMedica International staff writers
Posted on 11 Nov 2013
One of the keys to healthful living with Type 1 and Type 2 diabetes is monitoring blood glucose levels to ensure they remain at stable levels, which can easily be done at home using electronic devices with a drop of blood. More...


A noninvasive technique has been devised that uses the resonance-enhanced pulsed photoacoustic spectroscopy in the ultrasound range using a newly designed, windowless resonator cell that could replace the need for a finger prick.

Scientists at the Johann Wolfgang Goethe-University (Frankfurt, Germany) have devised a novel, noninvasive way to make monitoring easier. They used an infrared laser light applied on top of the skin, to measure sugar levels in the fluid in and under skin cells to read blood sugar levels.

Their new optical approach uses photoacoustic spectroscopy (PAS) to measure glucose by its mid-infrared absorption of light. A painless pulse of laser light applied externally to the skin is absorbed by glucose molecules and creates a measurable sound signature that the team refers to as "the sweet melody of glucose." This signal enables the scientists to detect glucose in skin fluids in seconds.

The data showing the skin cell-glucose levels at one-hundredth of a millimeter beneath the skin is related to blood glucose levels. Previous attempts to use PAS in this manner have been hampered by distortion related to changes of air pressure, temperature, and humidity caused by the contact with living skin. To overcome these constraints, the team devised a design innovation of open, windowless cell architecture. While it is still experimental and would have to be tested and approved by regulatory agencies before becoming commercially available as the team continues to refine it.

The scientists are working in close collaboration with Elté Sensoric (Gelnhausen, Germany) as an industrial partner, and they expect to have a small shoebox-sized device ready in three years, followed by a portable glucometer some years later. The authors concluded that their photoacoustic cell could be applied for measurements of glucose in human epidermis in the fingerprint region. However, it can be used for other solid samples with relevant absorption bands in the middle infrared or even other spectral regions if the laser source covers relevant absorption bands of the sample. The study was published in the August 2013 issue of the Review of Scientific Instruments.

Related Links:

Johann Wolfgang Goethe-University
Elté Sensoric



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.